Skip to main content

News Archive

News Archive - School of Medicine

NIH Helps UC San Diego Researchers Repurpose Sanofi Pain Drug for Tropical Disease

July 27, 2015

The National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), has awarded James McKerrow, MD, PhD, dean of the University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, with a 2015 New Therapeutic Uses Award.

UC San Diego Health and La Jolla Institute Announce New Affiliation

July 27, 2015

UC San Diego Health, with the University of California, San Diego School of Medicine, has entered into a multi-year affiliation agreement with La Jolla Institute for Allergy and Immunology (LJI) designed to deepen existing collaborative relationships, boost basic research of diseases of the immune system and more quickly introduce new clinical treatments and therapies.

Court Rules UC San Diego is Rightful Owner of Alzheimer’s Disease Cooperative Study Data

July 27, 2015

On Friday, July 24, Superior Court Judge Judith F. Hayes found in favor of the University of California Regents’ request for a preliminary injunction to restore rightful custody and control of Alzheimer’s Disease Cooperative Study (ADCS) data to UC San Diego.

UC San Diego Health Ranks #1 by U.S. News & World Report

July 20, 2015

Once again, UC San Diego Health and its hospitals are ranked #1 in San Diego, and recognized among the best in the nation, by U.S. News & World Report for 2015-16. The annual U.S. News “Best Hospitals” rankings distinguish hospitals that excel in treating the most challenging health conditions.

UC San Diego Health and AccentCare Announce Joint Venture for Home Health Care Services

July 14, 2015

UC San Diego Health and AccentCare have created a jointly owned home health services agency to serve UC San Diego Health patients in San Diego and surrounding communities. The new agency is designed to provide a comprehensive continuum of care after patients have been discharged from the hospital to facilitate efficient communication, improved safety, and faster healing.

Nutrients Turn on Key Tumor Signaling Molecule, Fueling Resistance to Cancer Therapy

July 13, 2015

Tumors can leverage glucose and other nutrients to resist targeted therapies directed at specific cellular molecules, according to researchers at University of California, San Diego School of Medicine and Ludwig Cancer Research. In the study, published this week in Proceedings of the National Academy of Sciences, the team used human tissue and mouse models to demonstrate that nutrients can strongly affect the signaling molecules that drive tumors in glioblastoma, a deadly brain cancer.

Learning Impacts How the Brain Processes What We See

July 13, 2015

From the smell of flowers to the taste of wine, our perception is strongly influenced by prior knowledge and expectations, a cognitive process known as top-down control. In a University of California, San Diego School of Medicine study, a research team led by Takaki Komiyama, PhD, assistant professor of neurosciences and neurobiology, reports that in mouse models, the brain significantly changed its visual cortex operation modes by implementing top-down processes during learning.

A New Wrinkle: Geometry of Brain’s Outer Surface Correlates With Genetic Heritage

July 9, 2015

Researchers at the University of California, San Diego and the School of Medicine have found that the three-dimensional shape of the cerebral cortex – the wrinkled outer layer of the brain controlling many functions of thinking and sensation – strongly correlates with ancestral background. The study opens the door to more precise studies of brain anatomy going forward and could eventually lead to more personalized medicine approaches for diagnosing and treating brain diseases.

UC San Diego and GSK Collaborate to Eradicate Cancer Stem Cells, Treat Leukemia

July 8, 2015

Researchers at the University of California, San Diego School of Medicine and Moores Cancer Center are working with GSK on a bench-to-bedside project to treat leukemia and other diseases by eliminating cancer stem cells. The collaboration is part of GSK’s Discovery Partnerships with Academia (DPAc) program, where academic partners become core members of drug-hunting teams. Catriona Jamieson, MD, PhD, associate professor of medicine and chief of the Division of Regenerative Medicine, will lead UC San Diego’s effort in the new DPAc team.

Epigenetic Driver of Glioblastoma Provides New Therapeutic Target

July 6, 2015

Using human tumor samples and mouse models, researchers at University of California, San Diego School of Medicine and Moores Cancer Center discovered that cancer stem cell properties are determined by epigenetic changes — chemical modifications cells use to control which genes are turned on or off.
Category navigation with Social links